Hideaki Mizumoto
Funabashi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment strategy changes for inflammatory bowel diseases in biologic era: results from a multicenter cohort in Japan, Far East 1000.
Journal: Scientific reports
Published: November 07, 2022
Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practice.
Journal: Cancer
Published: August 15, 2022
Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice.
Journal: BMC gastroenterology
Published: July 27, 2022
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study.
Journal: Oncology letters
Published: June 24, 2022
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.
Journal: Liver cancer
Published: September 14, 2020
Safety and Efficacy of Early Tube Removal Following Percutaneous Transhepatic Gallbladder Drainage: an Observational Study.
Journal: Surgical laparoscopy, endoscopy & percutaneous techniques
Published: January 24, 2020
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.
Journal: Investigational new drugs
Published: March 30, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026